Estacio Participacoes S/A ADS (ECPCY) Financials Nov 14,
Estacio Participacoes S/A ADS (ECPCY) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Estacio Participacoes S/A ADS
Fiscal year is January-December. All values BRL millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.01B 1.02B 1.15B 1.38B 1.73B
Cost of Goods Sold (COGS) incl. D&A 830.55M 833.44M 780.68M 895.1M 1.06B
COGS excluding D&A 820.72M 820.4M 738.46M 833.89M 987.87M
Depreciation & Amortization Expense 9.83M 13.03M 42.22M 61.21M 67.2M
Depreciation - - 29.95M - 42.29M
Amortization of Intangibles - - 12.27M - 24.92M
Gross Income 178.26M 182.72M 367.76M 488.19M 675.94M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 128.04M 128.42M 290.92M 358.14M 420.14M
Research & Development 0 0 0 0 0
Other SG&A 128.04M 128.42M 290.92M 358.14M 420.14M
Other Operating Expense 4.48M 5.18M 4.66M (1.01M) 4.94M
Unusual Expense 426,000 1.03M 3.3M 0 18.11M
EBIT after Unusual Expense (426,000) (1.03M) (3.3M) 0 (18.11M)
Non Operating Income/Expense 13.28M 15.29M 11.42M 1.04M 3.49M
Non-Operating Interest Income 19.04M 16.44M 8.03M 13.21M 48.94M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 9.33M 5.99M 9.65M 30.38M 28.44M
Gross Interest Expense 9.33M 5.99M 9.65M 30.38M 28.44M
Interest Capitalized 0 0 0 0 0
Pretax Income 68.3M 73.83M 78.68M 114.93M 256.74M
Income Tax 4.94M (6.83M) 5.07M 5.24M 12.03M
Income Tax - Current Domestic 5.41M 6.13M 1.29M 3.74M 13.77M
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (470,000) (12.97M) 3.78M 1.5M (1.74M)
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - - - - 0
Consolidated Net Income 63.37M 80.66M 73.61M 109.69M 244.71M
Minority Interest Expense 0 0 0 0 0
Net Income 63.37M 80.66M 73.61M 109.69M 244.71M
Extraordinaries & Discontinued Operations 0 0 (3.45M) 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 (3.45M) 0 0
Net Income After Extraordinaries 63.37M 80.66M 70.16M 109.69M 244.71M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 63.37M 80.66M 73.61M 109.69M 244.71M
EPS (Basic) 0.27 0.34 0.28 0.44 0.83
Basic Shares Outstanding 235.76M 238.54M 246.6M 247.27M 293.9M
EPS (Diluted) 0.26 0.33 0.27 0.44 0.83
Diluted Shares Outstanding 244.73M 246.17M 260.47M 250.28M 294.31M
EBITDA 55.57M 62.15M 114.4M 192.27M 318.06M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...
Continue Reading
Shenzhen Steps into the Arbitration Spotlight In a move that's bound to tweak some eyebrows in the legal realm, Shenzhen just hosted the 2026 Foreign Direct Investment International Arbitration Moot (FDI Moot) Global Finals. This marks the first time the finals have landed on Chinese soil, and folks, that's a big deal. It’s a hefty nod to China's expanding credibility...
Continue Reading
A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...
Continue Reading
Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...
Continue Reading
Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...
Continue Reading
Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...
Continue Reading
Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...
Continue Reading
Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...
Continue Reading
Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...
Continue Reading
Why a Trade Fair Needs Lion Dances October 2026 marks a time when talking about a trade fair means diving headfirst into a whirlpool of global exchange and cultural tango we don’t often see in the West. Yeah, I'm looking at you, Canton Fair—a long-runner over in China that's managed to haul in the globe to not just showcase wares, but bring people together in a clash...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of Horizon Resources Inc.'s New Valuation Horizon Petroleum Ltd. (TSXV: HPL) is thrilled to share the latest updates on significant reserve and resource assessments for its operations in Poland. The company has successfully acquired key assets in the Bielsko-Biala concession affecting the Lachowice gas field. Enjoying the benefits of acquisition through its...
Continue Reading
Revolutionizing Women's Lingerie: Thirdlove's New TempSync™ Collection Thirdlove, a pioneering lifestyle brand dedicated to women's comfort and inclusion, has officially unveiled its innovative TempSync collection. This unique line of temperature-regulating lingerie comprises a T-shirt bra, wireless bra, and hipster, all designed to support women during perimenopause...
Continue Reading
Queclink's Innovative WR310 Series: A New Era of Connectivity Queclink, a global leader in IoT solutions, has proudly launched the WR310 Series, an advanced industrial router designed to meet the burgeoning demands of modern industrial networks. Tailored to provide seamless connectivity, the WR310 Series is set to redefine industrial communications while elevating...
Continue Reading
PRA Celebrates New Steps Towards Healthcare Price Transparency Ensuring patients receive accurate pricing information before they receive care has become a crucial conversation in healthcare. The Patient Rights Advocate (PRA) has taken a momentous stance by applauding recent actions that promote transparency within the healthcare sector. PRA's Support for HHS Initiatives...
Continue Reading
Stifel Financial Corp Shows Significant Q3 Growth Stifel Financial Corp (NYSE: SF) has announced remarkable growth in its third-quarter financial performance. With net revenue reaching $1.23 billion, the company marked a significant 17% rise year-over-year. This impressive figure is notable as it stands as the second-highest quarterly revenue in its history. Additionally,...
Continue Reading